2017年美国乳腺癌统计:各州黑人女性死亡率差异
美国癌症协会发布2017年美国女性乳腺癌统计,预计新发侵袭性乳腺癌252,710例、死亡40,610例。2005至2014年亚裔/太平洋岛民、非西班牙裔黑人和西班牙裔女性发病率上升,激素受体阳性乳腺癌增加而阴性减少。1989至2015年乳腺癌死亡率下降39%,但非西班牙裔黑人女性死亡率仍比白人女性高39%(MRR 1.39, 95%CI 1.35-1.43),各州超额死亡率从20%到66%不等。
要点
- 2017年美国预计新发侵袭性乳腺癌252,710例,死亡40,610例。
- 2005至2014年亚裔/太平洋岛民、非西班牙裔黑人和西班牙裔女性发病率上升。
- 2015年非西班牙裔黑人女性乳腺癌死亡率比白人女性高39%(MRR 1.39, 95%CI 1.35-1.43)。
核心结论
- 1989至2015年美国乳腺癌死亡率下降39%,相当于避免322,600例死亡。
- 非西班牙裔黑人女性乳腺癌死亡率仍高于白人女性,但差距自2011年以来未再扩大。
研究设计与样本
- 美国癌症协会基于美国女性乳腺癌发病、死亡、生存和筛查数据进行的统计分析。
主要发现
- 2005至2014年乳腺癌总发病率在亚裔/太平洋岛民女性中每年增加1.7%,非西班牙裔黑人女性增加0.4%,西班牙裔女性增加0.3%,非西班牙裔白人和美国印第安人/阿拉斯加原住民女性保持稳定。
- 发病率上升由激素受体阳性乳腺癌增加驱动,所有种族/民族组均增加,而激素受体阴性乳腺癌发病率下降。
- 2006至2015年所有种族/民族组(包括美国印第安人/阿拉斯加原住民)乳腺癌死亡率均下降。
- 2015年非西班牙裔黑人女性乳腺癌死亡率比非西班牙裔白人女性高39%(MRR 1.39; 95%CI 1.35-1.43)。
- 各州黑人女性超额死亡率从内华达州的20%(MRR 1.20; 95%CI 1.01-1.42)到路易斯安那州的66%(MRR 1.66; 95%CI 1.54-1.79)。
临床怎么用
- 改善所有人群的医疗可及性可能消除乳腺癌死亡率的种族差异并加速全国死亡下降。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 252,710 new cases of invasive breast cancer and 40,610 breast cancer deaths are expected to occur among US women in 2017. From 2005 to 2014, overall breast cancer incidence rates increased among Asian/Pacific Islander (1.7% per year), non-Hispanic black (NHB) (0.4% per year), and Hispanic (0.3% per year) women but were stable in non-Hispanic white (NHW) and American Indian/Alaska Native (AI/AN) women. The increasing trends were driven by increases in hormone receptor-positive breast cancer, which increased among all racial/ethnic groups, whereas rates of hormone receptor-negative breast cancers decreased. From 1989 to 2015, breast cancer death rates decreased by 39%, which translates to 322,600 averted breast cancer deaths in the United States. During 2006 to 2015, death rates decreased in all racial/ethnic groups, including AI/ANs. However, NHB women continued to have higher breast cancer death rates than NHW women, with rates 39% higher (mortality rate ratio [MRR], 1.39; 95% confidence interval [CI], 1.35-1.43) in NHB women in 2015, although the disparity has ceased to widen since 2011. By state, excess death rates in black women ranged from 20% in Nevada (MRR, 1.20; 95% CI, 1.01-1.42) to 66% in Louisiana (MRR, 1.66; 95% CI, 1.54, 1.79). Notably, breast cancer death rates were not significantly different in NHB and NHW women in 7 states, perhaps reflecting an elimination of disparities and/or a lack of statistical power. Improving access to care for all populations could eliminate the racial disparity in breast cancer mortality and accelerate the reduction in deaths from this malignancy nationwide. CA Cancer J Clin 2017;67:439-448. © 2017 American Cancer Society.
引用
- DeSantis CE, Ma J, Goding Sauer A, et al. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017. PMID: 28972651. doi:10.3322/caac.21412
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。